Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Scientists identify signaling pathway and receptor for thymosin beta 4

Scientists identify signaling pathway and receptor for thymosin beta 4

Experts formulate research related to psychological adjustment and traumatic brain injury

Experts formulate research related to psychological adjustment and traumatic brain injury

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Studies explore lifestyle's influence on wellness and brain health

Studies explore lifestyle's influence on wellness and brain health

U-M researcher awarded $600,000 grant for study of progesterone in treatment of children with TBI

U-M researcher awarded $600,000 grant for study of progesterone in treatment of children with TBI

Archives of Physical Medicine and Rehabilitation publishes articles on TBI

Archives of Physical Medicine and Rehabilitation publishes articles on TBI

Neuropsychologist advices soldiers struggling with mild traumatic brain injury

Neuropsychologist advices soldiers struggling with mild traumatic brain injury

Study reveals a potential target for treating brain trauma

Study reveals a potential target for treating brain trauma

Molecular imaging technique pinpoints changes that take place in injured brain

Molecular imaging technique pinpoints changes that take place in injured brain

African Americans more likely to have uterine cancer recurrence

African Americans more likely to have uterine cancer recurrence

Oxygen Biotherapeutics receives $245,000 grant under PPACA 2010

Oxygen Biotherapeutics receives $245,000 grant under PPACA 2010

FDA approves NUEDEXTA capsules for pseudobulbar affect

FDA approves NUEDEXTA capsules for pseudobulbar affect

Mary Ann Liebert launches Brain Connectivity journal

Mary Ann Liebert launches Brain Connectivity journal

Survive & Thrive event assists OIF/OEF service members with traumatic brain injury

Survive & Thrive event assists OIF/OEF service members with traumatic brain injury

UCI scientists receive CIRM grants to improve stem cell treatments

UCI scientists receive CIRM grants to improve stem cell treatments

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

Neuralstem updates Phase I human clinical trial of spinal cord stem cells for ALS

Neuralstem updates Phase I human clinical trial of spinal cord stem cells for ALS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.